Saudi Medical Journal最新文献

筛选
英文 中文
WHO launches first-ever guidelines on meningitis diagnosis, treatment and care. 世卫组织首次发布脑膜炎诊断、治疗和护理指南。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-05-01
{"title":"WHO launches first-ever guidelines on meningitis diagnosis, treatment and care.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 5","pages":"582-583"},"PeriodicalIF":1.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giving voice to the youngest patients: Rethinking pediatric communication in pharmacy practice. 让最年轻的患者发声:重新思考药房实践中的儿科沟通。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-05-01 DOI: 10.15537/smj.2025.46.5.20250338
Haifa F Alotaibi
{"title":"Giving voice to the youngest patients: Rethinking pediatric communication in pharmacy practice.","authors":"Haifa F Alotaibi","doi":"10.15537/smj.2025.46.5.20250338","DOIUrl":"10.15537/smj.2025.46.5.20250338","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 5","pages":"576-577"},"PeriodicalIF":1.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144042111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast cancer incidence after hormonal treatment for infertility: A meta-analysis of population-based studies. 不孕症激素治疗后乳腺癌发病率:基于人群研究的荟萃分析。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-05-01 DOI: 10.15537/smj.2025.46.5.20240544
Amal Y Zaman, Lama S Alrefai, Dorar F Alharbi, Rahaf A Khurmi, Leen M Abuanq, Ajyal A Aljohani, Ibrahim M Dighriri, Nada Elnugomi
{"title":"Breast cancer incidence after hormonal treatment for infertility: A meta-analysis of population-based studies.","authors":"Amal Y Zaman, Lama S Alrefai, Dorar F Alharbi, Rahaf A Khurmi, Leen M Abuanq, Ajyal A Aljohani, Ibrahim M Dighriri, Nada Elnugomi","doi":"10.15537/smj.2025.46.5.20240544","DOIUrl":"10.15537/smj.2025.46.5.20240544","url":null,"abstract":"<p><strong>Objectives: </strong>To comprehensively understand the relationship between infertility medications and the risk of breast cancer (BC) in females.</p><p><strong>Methods: </strong>Relevant literature search using different databases (PubMed, The Cochrane Library, Embase, Scopus, and Web of Sciences) following preferred reporting items for systematic reviews and meta-analyses guidelines was carried out from 2003-2023. Population-based studies comparing the incidence of BC after hormonal fertility treatment and a control group were included. In addition, random and fixed effect models were used to carry out meta-analyses.</p><p><strong>Results: </strong>A total of 15 studies involving 92,555 women were included in this review. The pooled analysis using risk ratios (RRs) showed no evidence of increased BC risk associated with hormonal fertility medications (RR=1.00, 95% confidence interval [CI]: [0.97-1.02], <i>p</i>=0.83). The level of heterogeneity, as indicated by the I² statistic, was low (32%), and the Q test was not statistically significant. Sensitivity analysis using a random-effects model yielded consistent findings, suggesting no increased BC development risk with infertility medications. Among the 4 studies reporting hazard ratios (HRs), a significant protective effect on BC risk was observed (HR=0.91, 95% CI: [0.88-0.94], <i>p</i><0.001). The heterogeneity was substantially high (I²=96%), and the Q test demonstrated statistical significance. Sensitivity analysis using a random-effects model showed that heterogeneity remained constant, suggesting that the heterogeneity was attributable to the methods utilized in the included studies rather than being a result of statistical heterogeneity. The overall effect, as determined by the HR, was 1.01 and was not statistically significant (<i>p</i>=0.94).</p><p><strong>Conclusion: </strong>This meta-analysis found no evidence of increased risk of BC following hormonal infertility treatment. However, the results should be illustrated cautiously, given the heterogeneity between studies.<b>PROSPERO No. ID: CRD42024569158</b>.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 5","pages":"441-449"},"PeriodicalIF":1.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144044166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical studies on anti-obesity medications in Arab countries. 阿拉伯国家抗肥胖药物的临床研究。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-05-01 DOI: 10.15537/smj.2025.46.5.20250126
Haifa F AlOtaibi, Hanan N Al Taib, Shadan AlMuhaidib, Saud Alshagrawi, Abdulmalik Almufarrih, Ola Alalmai, Sahar Alnaserallah, Najla Alodah, Saleh A Alqahtani, Waleed Alhazzani
{"title":"Clinical studies on anti-obesity medications in Arab countries.","authors":"Haifa F AlOtaibi, Hanan N Al Taib, Shadan AlMuhaidib, Saud Alshagrawi, Abdulmalik Almufarrih, Ola Alalmai, Sahar Alnaserallah, Najla Alodah, Saleh A Alqahtani, Waleed Alhazzani","doi":"10.15537/smj.2025.46.5.20250126","DOIUrl":"10.15537/smj.2025.46.5.20250126","url":null,"abstract":"<p><strong>Objectives: </strong>To identify and summarize studies carried out in Arab countries on anti-obesity medications (AOMs), with a focus on the types of medications investigated, study designs, and the efficacy/effectiveness and safety metrics reported.</p><p><strong>Methods: </strong>We carried out a comprehensive scoping review of primary studies examining the use of AOMs in adult Arab populations. Five databases (Medline, Embase, Cochrane Library, Index Medicus for the Eastern Mediterranean Region, and e-Marefa) were searched for English-language publications up to October 2024. Data extraction was carried out on study characteristics, participant demographics, interventions, and outcomes related to weight reduction, metabolic parameters, and side effects. The risk of bias (RoB) was assessed using the Newcastle-Ottawa scale for non-randomized studies and a modified RoB tool for randomized controlled trials.</p><p><strong>Results: </strong>A total of 59 clinical studies published between 2014-2024 were included. The majority (89.8%) were observational in design. Most studies were carried out in Saudi Arabia (40.7%) and the United Arab Emirates (20.3%). Glucagon-like peptide-1 receptor agonists were investigated in 72.9% of the studies, with liraglutide being the most frequently studied agent (54.2%). The most commonly reported efficacy outcomes included changes in total body weight (45.8%), body mass index (39.0%), and the proportion of weight loss (28.8%). Gastrointestinal side effects were reported in 32.2% of patients across studies.</p><p><strong>Conclusion: </strong>Despite the growing body of research on AOMs in Arab countries, most studies remain observational and focus primarily on earlier-generation agents. There is a need for randomized controlled trials to evaluate the efficacy and safety of newer AOMs, such as semaglutide and tirzepatide, within Arab populations to inform culturally and genetically tailored obesity management strategies.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 5","pages":"459-477"},"PeriodicalIF":1.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising ranking of Saudi universities in global science. 沙特大学在全球科学领域的排名不断上升。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-04-01 DOI: 10.15537/smj.2025.46.4.20240730
Muhammad Omair Sultan Meo, Muhammad Zain Sultan Meo
{"title":"Rising ranking of Saudi universities in global science.","authors":"Muhammad Omair Sultan Meo, Muhammad Zain Sultan Meo","doi":"10.15537/smj.2025.46.4.20240730","DOIUrl":"https://doi.org/10.15537/smj.2025.46.4.20240730","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 4","pages":"429-430"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12010491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of DIGIROP- Birth and DIGIROP- Screen for the discovery of retinopathy of prematurity requiring treatment in preterm births in Saudi Arabia. DIGIROP- Birth和DIGIROP-筛查在沙特阿拉伯早产儿中发现需要治疗的早产儿视网膜病变的验证
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-04-01 DOI: 10.15537/smj.2025.46.4.20240773
Huda K Ahmedhussain, Lina H Raffa, Amal M Alosaimif, Sarah K Alessa, Suzan Y Alharbi, Hashem Almarzouki, Mansour A AlQurashi
{"title":"Validation of DIGIROP- Birth and DIGIROP- Screen for the discovery of retinopathy of prematurity requiring treatment in preterm births in Saudi Arabia.","authors":"Huda K Ahmedhussain, Lina H Raffa, Amal M Alosaimif, Sarah K Alessa, Suzan Y Alharbi, Hashem Almarzouki, Mansour A AlQurashi","doi":"10.15537/smj.2025.46.4.20240773","DOIUrl":"https://doi.org/10.15537/smj.2025.46.4.20240773","url":null,"abstract":"<p><strong>Objectives: </strong>To validate 2 DIGIROP prediction models for retinopathy of prematurity (ROP) type 1 and compare them to other weight-based algorithms in a premature Saudi Arabian infant cohort.</p><p><strong>Methods: </strong>Preterm infants of 24-30 weeks' gestational age (GA) or body weight (BW) of ≤1500g who were admitted to the neonatal units of 2 Jeddah tertiary centers between January 2015 and September 2021 were included (N=363). The DIGIROP-Birth employed the birth GA, gender, birth weight, and age at ROP onset as predictors. The area under the receiver operating characteristic curve (AUC) with 95% confidence interval, specificity, and sensitivity were projected. The DIGIROP-Screen risk of risk were identified at 6-14 weeks postnatal age (PNA).</p><p><strong>Results: </strong>The mean GA was 27.94±1.6 weeks and the mean BW was 1068.2±269.2 g. The DIGIROP-Birth had a sensitivity of 93.8%; specificity of 48.9%; AUC of 0.70; and accuracy of 52.9%. For DIGIROP-Screen, the AUC for models spanning PNA 6-14 weeks varied from 0.68-0.83, and sensitivity varied from 73.3-96.8%. The DIGIROP-Birth and DIGIROP-Screen showed the highest accuracy and AUC value in comparison to other ROP prediction models.</p><p><strong>Conclusion: </strong>The 2 models demonstrated high predictive capacity for type 1 ROP risk assessment in this cohort. The potential of these tools for identifying high-risk infants and avoiding standard ROP screening in low-risk infants needs to be verified through large-scale studies.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 4","pages":"345-351"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12010494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144023103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An exploration of serum 25-hydroxyvitamin D levels after unstable femoral intertrochanteric fractures in community-dwelling elderly. 社区老年人不稳定股骨粗隆间骨折后血清25-羟基维生素D水平的探讨。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-04-01 DOI: 10.15537/smj.2025.46.4.20241121
Hakan Zora, Gökhan Bayrak
{"title":"An exploration of serum 25-hydroxyvitamin D levels after unstable femoral intertrochanteric fractures in community-dwelling elderly.","authors":"Hakan Zora, Gökhan Bayrak","doi":"10.15537/smj.2025.46.4.20241121","DOIUrl":"https://doi.org/10.15537/smj.2025.46.4.20241121","url":null,"abstract":"<p><strong>Objectives: </strong>Inadequate vitamin D is related to increased fall risk, which leads to hip fractures among the elderly. Therefore, this study aimed to explore vitamin D levels and the variables potentially influencing the total hospitalization time of community-dwelling elderly patients with unstable femoral intertrochanteric fractures.</p><p><strong>Methods: </strong>Between 2020-2024, 75 elderly patients treated with total hip replacement (THR) were retrospectively analyzed. Patients were divided into the deficient (<20 ng/mL, n=46), insufficient (20 to 29.99 ng/mL, n=16), and normal (≥30 ng/mL, n=13) serum 25-hydroxyvitamin D (25(OH)D) groups. Presence of delirium status, postoperative intensive care entrance, number of chronic diseases, preoperative waiting, and total hospitalization time after THR were recorded.</p><p><strong>Results: </strong>The cohorts' mean serum 25(OH)D level was 20.11ng/mL. The deficient, insufficient, and normal serum 25(OH)D level groups displayed no significant difference in the postoperative intensive care entrance (<i>p</i>=0.547) and the presence of delirium (<i>p</i>=0.947). The multiple linear regression model indicated that elderly patients' total hospitalization increases with the coefficients as the preoperative waiting time (β=0.466, <i>p</i>=0.001) and the number of chronic diseases (β=0.263, <i>p</i>=0.011) increase. Serum 25(OH)D level did not impact patients' total hospitalization time (β=-0.072, <i>p</i>=0.474).</p><p><strong>Conclusion: </strong>This study indicated that community-dwelling elderly patients with unstable femoral intertrochanteric fractures had significantly decreased serum 25(OH)D levels. Reducing preoperative waiting time and monitoring and addressing chronic diseases may decrease total hospitalization. Efforts should focus on achieving and maintaining adequate vitamin D levels through supplementation post-hospitalization.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 4","pages":"372-377"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12010498/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144015499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum and cord blood neutrophil gelatinase associated lipocalin levels in pregnant women with gestational diabetes mellitus and its association with tumor necrosis factor-alpha: A cross-sectional study from Tripura, India. 妊娠期糖尿病孕妇血清和脐带血中性粒细胞明胶酶相关脂钙蛋白水平及其与肿瘤坏死因子- α的关系:来自印度特里普拉的横断面研究
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-04-01 DOI: 10.15537/smj.2025.46.4.20240964
Bidhan Goswami, Sumit S Das, Partha S Pal, Partha Saha, Shauli Sengupta, Manti Debnath
{"title":"Serum and cord blood neutrophil gelatinase associated lipocalin levels in pregnant women with gestational diabetes mellitus and its association with tumor necrosis factor-alpha: A cross-sectional study from Tripura, India.","authors":"Bidhan Goswami, Sumit S Das, Partha S Pal, Partha Saha, Shauli Sengupta, Manti Debnath","doi":"10.15537/smj.2025.46.4.20240964","DOIUrl":"https://doi.org/10.15537/smj.2025.46.4.20240964","url":null,"abstract":"<p><strong>Objectives: </strong>To examine the significance of neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-alpha (TNF-α) in women with gestational diabetes mellitus (GDM) and their correlation with insulin resistance and metabolic markers.</p><p><strong>Methods: </strong>Blood samples from maternal and cord sources were obtained from 289 pregnant women, divided into GDM, prediabetic, and normal pregnancy groups. Serum levels of NGAL, TNF-α, insulin, fasting blood sugar (FBS), homeostasis model assessment-estimated insulin resistance (HOMA-IR), triglycerides, cholesterol, and so on were measured. Statistical analyses, including the Kruskal-Wallis test and Mann-Whitney U test, were used to compare NGAL levels across patient groups and ethnicities.</p><p><strong>Results: </strong>Women with GDM showed significantly higher serum NGAL and TNF-α levels compared to prediabetic and normal pregnancy groups. The NGAL levels positively correlated with key metabolic markers such as FBS, insulin, HOMA-IR, triglycerides, and cholesterol, suggesting a link between elevated NGAL and insulin resistance. In the GDM group, there was also a positive association (r=0.366) between NGAL and TNF-α values. No significant variation in NGAL levels was observed between non-tribal and tribal women.</p><p><strong>Conclusion: </strong>Elevated levels of NGAL and TNF-α in women with GDM are linked to increased insulin resistance, excessive gestational weight gain, and higher neonatal morbidity risk. These findings underscore the possible involvement of these inflammatory markers in the development of GDM, emphasizing the need for targeted management of both gestational weight gain and inflammation in GDM patients.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 4","pages":"352-357"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12010489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144028310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Many pregnancy-related complications going undetected and untreated - WHO. 许多妊娠相关并发症未被发现和治疗-世卫组织。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-04-01
{"title":"Many pregnancy-related complications going undetected and untreated - WHO.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 4","pages":"434-435"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12010497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study of pregnancy risks in different maternal age groups. 不同产妇年龄组妊娠风险的比较研究。
IF 1.7 4区 医学
Saudi Medical Journal Pub Date : 2025-04-01 DOI: 10.15537/smj.2025.46.4.20240555
Amala Sunder, Yusuf Khaled Hadi, Noor Ammar Alkhuzaei, Nayla Jamal Bushaqer, Haya Isa Al Khalifa, Basma Darwish, Nawal Dayoub
{"title":"Comparative study of pregnancy risks in different maternal age groups.","authors":"Amala Sunder, Yusuf Khaled Hadi, Noor Ammar Alkhuzaei, Nayla Jamal Bushaqer, Haya Isa Al Khalifa, Basma Darwish, Nawal Dayoub","doi":"10.15537/smj.2025.46.4.20240555","DOIUrl":"https://doi.org/10.15537/smj.2025.46.4.20240555","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate and compare pregnancy complications associated with varying maternal age groups.</p><p><strong>Methods: </strong>A retrospective analysis of singleton pregnancy outcomes at Bahrain Defense Force Hospital from January to December 2022. The study population was divided into 4 age groups: <25 years, 25-29 years, 30-34 years, and ≥35 years. Data on demographics, maternal and fetal characteristics were collected, and statistical significance was set at <i>p</i><0.05. Univariate logistic regression was performed to analyze maternal and neonatal outcomes, adjusting for maternal factors.</p><p><strong>Results: </strong>The study included 2,972 women aged 17-55. Significant associations were found between maternal age and outcomes. Body mass index (BMI) was significantly linked to age (<i>p</i><0.01), with younger women having lower BMI. Gestational diabetes mellitus (GDM) was more common in women ≥35 years (11.5%) vs. those <25 years (6.6%, <i>p</i>=0.027). Intrauterine growth restriction (IUGR) was more prevalent in the <25 years age group (<i>p</i>=0.041).Logistic regression showed women 30-34 years had a lower risk of GDM compared to 25-29 years (odds ratio [OR]: 0.544, CI: 0.365-0.811), and women <25 years had a higher risk of preterm delivery (OR: 1.365, CI: 1.015-1.837).</p><p><strong>Conclusion: </strong>Maternal age is an independent risk factor for various adverse outcomes. Younger women (<25) are at higher risk for preterm delivery and IUGR, while older women (≥35) have higher rates of GDM.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 4","pages":"378-387"},"PeriodicalIF":1.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12010492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信